Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial (SYH2062-003) of the SYH2062 injection developed by the group to treat essential hypertension in adults has been officially launched at the first center in China.

Zhitongcaijing · 3d ago
Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial (SYH2062-003) of the SYH2062 injection developed by the group to treat essential hypertension in adults has been officially launched at the first center in China.